Roche Holdings AG Basel (OTCMKTS:RHHBY) Hits New 52-Week High at $36.58

Roche Holdings AG Basel ADR (OTCMKTS:RHHBY) shares hit a new 52-week high on Thursday . The stock traded as high as $36.58 and last traded at $36.56, with a volume of 1664742 shares. The stock had previously closed at $35.74.

A number of brokerages have commented on RHHBY. ValuEngine downgraded shares of Roche Holdings AG Basel from a “hold” rating to a “sell” rating in a research report on Tuesday, September 10th. Deutsche Bank raised shares of Roche Holdings AG Basel from a “hold” rating to a “buy” rating in a research report on Thursday, June 20th. UBS Group raised shares of Roche Holdings AG Basel from a “neutral” rating to a “buy” rating in a research report on Friday, July 26th. Liberum Capital downgraded shares of Roche Holdings AG Basel from a “buy” rating to a “hold” rating in a research report on Thursday, June 20th. Finally, Zacks Investment Research raised shares of Roche Holdings AG Basel from a “hold” rating to a “buy” rating and set a $37.00 price objective on the stock in a research report on Tuesday, July 9th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and six have issued a buy rating to the company’s stock. Roche Holdings AG Basel presently has a consensus rating of “Hold” and a consensus price target of $37.00.

The firm’s fifty day moving average price is $35.37 and its 200-day moving average price is $34.27. The firm has a market cap of $249.90 billion, a price-to-earnings ratio of 15.76, a PEG ratio of 2.25 and a beta of 0.49.

Several institutional investors have recently modified their holdings of RHHBY. Douglass Winthrop Advisors LLC boosted its holdings in shares of Roche Holdings AG Basel by 9.2% in the 2nd quarter. Douglass Winthrop Advisors LLC now owns 637,978 shares of the company’s stock valued at $22,393,000 after buying an additional 53,702 shares in the last quarter. Scout Investments Inc. boosted its stake in Roche Holdings AG Basel by 15.9% during the 2nd quarter. Scout Investments Inc. now owns 103,699 shares of the company’s stock worth $3,651,000 after purchasing an additional 14,204 shares during the period. Boston Private Wealth LLC boosted its stake in Roche Holdings AG Basel by 46.6% during the 2nd quarter. Boston Private Wealth LLC now owns 10,240 shares of the company’s stock worth $361,000 after purchasing an additional 3,254 shares during the period. Diversified Trust Co boosted its stake in Roche Holdings AG Basel by 1.2% during the 2nd quarter. Diversified Trust Co now owns 48,764 shares of the company’s stock worth $1,717,000 after purchasing an additional 599 shares during the period. Finally, Sky Investment Group LLC boosted its stake in Roche Holdings AG Basel by 0.7% during the 2nd quarter. Sky Investment Group LLC now owns 63,466 shares of the company’s stock worth $2,228,000 after purchasing an additional 445 shares during the period. Institutional investors and hedge funds own 0.32% of the company’s stock.

About Roche Holdings AG Basel (OTCMKTS:RHHBY)

Roche Holding AG engages in the diagnostics and prescription pharmaceuticals businesses in Switzerland, Germany, and internationally. It offers pharmaceutical products for treating anaemia, anticoagulation therapy, bone, cardiovascular, central nervous system, chlamydia, coagulation, dermatology, diabetes, gonorrhea, gout, hemostasis disorders, hepatitis B and C, HIV/AIDS, HPV, inflammatory and autoimmune, intensive care medicine, kidney and urogenital tract, leukemia, lipid and liver disorders, lymphoma, metabolic disorders, obesity, occult blood testing, ophthalmology, osteoporosis, pancreatitis, respiratory disorders, rheumatoid arthritis, sepsis, sexually transmitted infections, skin cancer, transplantation, tuberculosis, urinary tract infections, and West Nile virus and infectious diseases.

Recommended Story: Calculate Your Return on Investment (ROI)

Receive News & Ratings for Roche Holdings AG Basel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holdings AG Basel and related companies with MarketBeat.com's FREE daily email newsletter.